Prospective, Multicenter, Self-controlled Clinical Trial to Validate Optical Ultrasonic Flow Ratio (OUFR)

NACompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

November 10, 2024

Primary Completion Date

April 7, 2025

Study Completion Date

June 30, 2025

Conditions
Fractional Flow ReserveCoronary Artery Disease
Interventions
DEVICE

FFR measurement and intravascular imaging

Participants undoing anticipated percutaneous coronary intervention will be performed wire-based FFR measurement, and intravascular imaging, including IVUS and integrated OCT-IVUS using a single cathete to assess the accurary of OUFR, using wire-based FFR measurement as the gold standard.

Trial Locations (5)

100034

Peking University First Hospital, Beijing

100083

Peking University Third Hospital, Beijing

101100

Beijing Luhe Hospital Capital Medical University, Beijing

163711

Harbin Medical University, Harbin

272067

Jining Medical University, Jining

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Peking University Third Hospital

OTHER

collaborator

Panovision

UNKNOWN

collaborator

Capital Medical University

OTHER

collaborator

The Second Affiliated Hospital of Harbin Medical University

OTHER

collaborator

Jining Medical University

OTHER

collaborator

Peking University First Hospital

OTHER

lead

Harbin Medical University

OTHER

NCT06726252 - Prospective, Multicenter, Self-controlled Clinical Trial to Validate Optical Ultrasonic Flow Ratio (OUFR) | Biotech Hunter | Biotech Hunter